References
- Audiger C, Rahman MJ, Yun TJ, Tarbell KV, Lesage S. The importance of dendritic cells in maintaining immune tolerance. 198. 2017:6;2223–31. doi:https://doi.org/10.4049/jimmunol.1601629.
- Bauer T, Zagorska A, Jurkin J, Yasmin N, Köffel R, Richter S, Gesslbauer B, Lemke G, Strobl H. 2012. Identification of Axl as a downstream effector of TGF-beta1 during Langerhans cell differentiation and epidermal homeostasis. J Exp Med. 209(11):2033–47.
- Bigley V, McGovern N, Milne P, Dickinson R, Pagan S, Cookson S, Haniffa M, Collin M. 2015. Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141 high XCR1+dendritic cells. J Leukoc Biol. 97(4):627–34.
- Bode C, Fox M, Tewary P, Steinhagen A, Ellerkmann RK, Klinman D, Baumgarten G, Hornung V, Steinhagen F. 2016. Human plasmacytoid dentritic cells elicit a Type I Interferon response by sensing DNA via the cGAS-STING signaling pathway. Eur J Immunol. 46(7):1615–21.
- Breton G, Zheng S, Valieris R, Tojal da Silva I, Satija R, Nussenzweig MC. 2016. Human dendritic cells (DCs) are derived from distinct circulating precursors that are precommitted to become CD1c+ or CD141+ DCs. J Exp Med. 213(13):2861–70.
- Bryant C, Fromm PD, Kupresanin F, Clark G, Lee K, Clarke C, Silveira PA, Suen H, Brown R, Newman E, et al. 2016. A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset. Immunol Cell Biol. 94(5):447–57. doi:https://doi.org/10.1038/icb.2015.116
- Cechim G, Chies JA. 2019. In vitro generation of human monocyte-derived dendritic cells methodological aspects in a comprehensive review. Anais Da Academia Brasileira De Ciências. 91(4). doi:https://doi.org/10.1590/0001-3765201920190310.
- Cernadas M, Lu J, Watts G, Brenner MB. 2009. CD1a expression defines an interleukin-12 producing population of human dendritic cells. Clin Exp Immunol. 155(3):523–33.
- Chopin M, Seillet C, Chevrier S, Wu L, Wang H, Morse HC, Belz GT, Nutt SL. 2013. Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks. J Exp Med. 210(13):2967–80.
- Cisse B, Caton ML, Lehner M, Maeda T, Scheu S, Locksley R, Holmberg D, Zweier C, den Hollander NS, Kant SG, et al. 2008. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell. 135(1):37–48. doi:https://doi.org/10.1016/j.cell.2008.09.016.
- Clark GJ, Silveira PA, Hogarth PM, Hart DNJ. 2019. The cell surface phenotype of human dendritic cells. Semin Cell Dev Biol. 86:3–14.
- Collin M, Bigley V. 2018. Human dendritic cell subsets: an update. Immunology. 154(1):3–20.
- Collin M, McGovern N, Haniffa M. 2013. Human dendritic cell subsets. Immunology. 140(1):22–30.
- De Monte A, Olivieri CV, Vitale S, Bailleux S, Castillo L, Giordanengo V, Maryanski JL, Segura E, Doglio A. 2016. CD1c-related dcs that express CD207/langerin, but are distinguishable from langerhans cells, are consistently present in human tonsils. Front Immunol. 7:197.
- Deluce-Kakwata-Nkor N, Lamendour L, Chabot V, Héraud A, Ivanovic Z, Halary F, Dehaut F, Velge-Roussel F. 2018. Differentiation of human dendritic cell subsets for immune tolerance induction. Transfus Clin Biol. 25(1):90–95.
- Dudek AM, Martin S, Garg AD, Agostinis P. 2013. Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity. Front Immunol. 4:438.
- Durand M, Segura E. 2015. The known unknowns of the human dendritic cell network. Front Immunol. 6:129.
- Evans VA, Lal L, Akkina R, Solomon A, Wright E, Lewin SR, Cameron PU. 2011. Thymic plasmacytoid dendritic cells are susceptible to productive HIV-1 infection and efficiently transfer R5 HIV-1 to thymocytes in vitro. Retrovirology. 8(1):43.
- Fehres CM, Bruijns SC, Sotthewes BN, Kalay H, Schaffer L, Head SR, de Gruijl TD, Garcia-Vallejo JJ, van Kooyk Y. 2015. Phenotypic and functional properties of human steady state CD14+ and CD1a+ antigen presenting cells and epidermal langerhans cells. PLoS One. 10(11):e0143519. doi:https://doi.org/10.1371/journal.pone.0143519.
- Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, Homey B, Barrat FJ, Zal T, Gilliet M, et al. 2009. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med. 206(9):1983–94. doi:https://doi.org/10.1084/jem.20090480.
- Guilliams M, van de Laar L. 2015. A Hitchhiker’s guide to myeloid cell subsets: practical implementation of a novel mononuclear phagocyte classification system. Front Immunol. 6:406.
- Harman AN, Bye CR, Nasr N, Sandgren KJ, Kim M, Mercier SK, Botting RA, Lewin SR, Cunningham AL, Cameron PU, et al. 2013. Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J Immunol. 190(1):66–79. doi:https://doi.org/10.4049/jimmunol.1200779.
- Hasegawa H, Matsumoto T. 2018. Mechanisms of tolerance induction by dendritic cells in vivo. Front Immunol. 9:350–350.
- Hemont C, Neel A, Heslan M, Braudeau C, Josien R. 2013. Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness. J Leukoc Biol. 93(4):599–609.
- Hieronymus T, Zenke M, Baek JH, Seré K. 2015. The clash of Langerhans cell homeostasis in skin: should I stay or should I go? Semin Cell Dev Biol. 41:30–38.
- Ito T, Liu YJ, Kadowaki N. 2005. Functional diversity and plasticity of human dendritic cell subsets. Int J Hematol. 81(3):188–96.
- Iwasaki A, Medzhitov R. 2015. Control of adaptive immunity by the innate immune system. Nat Immunol. 16(4):343–53.
- Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE, Chen CJJ, Dunbar PR, Wadley RB, Jeet V, et al. 2010. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med. 207(6):1247–60. doi:https://doi.org/10.1084/jem.20092140
- Kaczmarek R, Pasciak M, Szymczak-Kulus K, Czerwinski M. 2017. CD1: a singed cat of the three antigen presentation systems. Arch Immunol Ther Exp (Warsz). 65(3):201–14.
- Kaushik S, Teque F, Patel M, Fujimura SH, Schmidt B, Levy JA. 2013. Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state. AIDS Res Hum Retroviruses. 29(3):501–10.
- Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson-Snipes L, Briere F, Chaussabel D, Zurawski G, Palucka AK, et al. 2008. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity. 29(3):497–510. doi:https://doi.org/10.1016/j.immuni.2008.07.013.
- Lauterbach H, Bathke B, Gilles S, Traidl-Hoffmann C, Luber CA, Fejer G, Freudenberg MA, Davey GM, Vremec D, Kallies A, et al. 2010. Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. J Exp Med. 207(12):2703–17. doi:https://doi.org/10.1084/jem.20092720.
- Lee J, Breton G, Oliveira TY, Zhou YJ, Aljoufi A, Puhr S, Cameron MJ, Sékaly R-P, Nussenzweig MC, Liu K, et al. 2015. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med. 212(3):385–99. doi:https://doi.org/10.1084/jem.20141442.
- Liu J, Cao X. 2015. Regulatory dendritic cells in autoimmunity: A comprehensive review. J Autoimmun. 63:1–12.
- Lozza L, Farinacci M, Bechtle M, Stäber M, Zedler U, Baiocchini A, Del Nonno F, Kaufmann SHE. 2014. Communication between human dendritic cell subsets in tuberculosis: requirements for naive CD4+ T cell stimulation. Front Immunol. 5:324.
- Lundberg K, Albrekt AS, Nelissen I, Santegoets S, de Gruijl TD, Gibbs S, Lindstedt M. 2013. Transcriptional profiling of human dendritic cell populations and models–unique profiles of in vitro dendritic cells and implications on functionality and applicability. PLoS One. 8(1):e52875.
- Mathan TS, Figdor CG, Buschow SI. 2013. Human plasmacytoid dendritic cells: from molecules to intercellular communication network. Front Immunol. 4:372.
- Matsui T, Connolly JE, Michnevitz M, Chaussabel D, Yu C-I, Glaser C, Tindle S, Pypaert M, Freitas H, Piqueras B, et al. 2009. CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions. J Immunol. 182(11):6815–23. doi:https://doi.org/10.4049/jimmunol.0802008.
- McGovern N, Chan JK, Ginhoux F. 2015. Dendritic cells in humans—from fetus to adult. Int Immunol. 27(2):65–72.
- McGovern N, Schlitzer A, Gunawan M, Jardine L, Shin A, Poyner E, Green K, Dickinson R, Wang X-N, Low D, et al. 2014. Human dermal CD14(+) cells are a transient population of monocyte-derived macrophages. Immunity. 41(3):465–77. doi:https://doi.org/10.1016/j.immuni.2014.08.006
- Merad M, Sathe P, Helft J, Miller J, Mortha A. 2013. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol. 31(1):563–604.
- Morelli AE, Thomson AW. 2007. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol. 7(8):610–21.
- Nizzoli G, Larghi P, Paroni M, Crosti MC, Moro M, Neddermann P, Caprioli F, Pagani M, De Francesco R, Abrignani S, et al. 2016. IL-10 promotes homeostatic proliferation of human CD8+memory T cells and, when produced by CD1c+DCs, shapes naive CD8+T-cell priming. Eur J Immunol. 46(7):1622–32. doi:https://doi.org/10.1002/eji.201546136.
- O’Brien M, Manches O, Bhardwaj N. 2013. Plasmacytoid dendritic cells in HIV infection. Adv Exp Med Biol. 762:71–107.
- O’Keeffe M, Mok WH, Radford KJ. 2015. Human dendritic cell subsets and function in health and disease. Cell Mol Life Sci. 72(22):4309–25.
- Obregon C, Kumar R, Pascual MA, Vassalli G, Golshayan D. 2017. Update on dendritic cell-induced immunological and clinical tolerance. Front Immunol. 8:1514.
- Ochoa MT, Loncaric A, Krutzik SR, Becker TC, Modlin RL. 2008. “Dermal dendritic cells” comprise two distinct populations: CD1+ dendritic cells and CD209+ macrophages. J Invest Dermatol. 128(9):2225–31.
- Palucka K, Banchereau J, Mellman I. 2010. Designing vaccines based on biology of human dendritic cell subsets. Immunity. 33(4):464–78.
- Patente TA, Pinho MP, Oliveira AA, Evangelista GCM, Bergami-Santos PC, Barbuto JAM 2019. Human dendritic cells: their heterogeneity and clinical application potential in cancer immunotherapy. Front Immunol. 9(3176). doi:https://doi.org/10.3389/fimmu.2018.03176.
- Qu C, Brinck-Jensen NS, Zang M, Chen K. 2014. Monocyte-derived dendritic cells: targets as potent antigen-presenting cells for the design of vaccines against infectious diseases. Int J Infect Dis. 19:1–5.
- Radford KJ, Tullett KM, Lahoud MH. 2014. Dendritic cells and cancer immunotherapy. Curr Opin Immunol. 27:26–32.
- Said A, Weindl G. 2015. Regulation of dendritic cell function in inflammation. J Immunol Res. 2015:743169.
- Satpathy AT, Kc W, Albring JC, Edelson BT, Kretzer NM, Bhattacharya D, Murphy TL, Murphy KM 2012. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J Exp Med. 209(6):1135–52. doi:https://doi.org/10.1084/jem.20120030.
- Schlitzer A, McGovern N, Ginhoux F. 2015. Dendritic cells and monocyte-derived cells: two complementary and integrated functional systems. Semin Cell Dev Biol. 41:9–22.
- Schlitzer A, McGovern N, Teo P, Zelante T, Atarashi K, Low D, Ho AS, See P, Shin A, Wasan P, et al. 2013. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity. 38(5):970–83. doi:https://doi.org/10.1016/j.immuni.2013.04.011.
- Schraml BU, Reis E Sousa C. 2015. Defining dendritic cells. Curr Opin Immunol. 32:13–20.
- Schultze JL, Aschenbrenner AC. 2019. Systems immunology allows a new view on human dendritic cells. Semin Cell Dev Biol. 86:15–23.
- Segura E, Amigorena S. 2013. Identification of human inflammatory dendritic cells. Oncoimmunology. 2(5):e23851.
- Segura E, Valladeau-Guilemond J, Donnadieu MH, Sastre-Garau X, Soumelis V, Amigorena S. 2012. Characterization of resident and migratory dendritic cells in human lymph nodes. J Exp Med. 209(4):653–60. doi:https://doi.org/10.1084/jem.20111457
- Sehgal K, Dhodapkar KM, Dhodapkar MV. 2014. Targeting human dendritic cells in situ to improve vaccines. Immunol Lett. 162(1 Pt A):59–67.
- Sichien D, Lambrecht BN, Guilliams M, Scott CL. 2017. Development of conventional dendritic cells: from common bone marrow progenitors to multiple subsets in peripheral tissues. Mucosal Immunol. 10(4):831–44. doi:https://doi.org/10.1038/mi.2017.8
- Sittig SP, Bakdash G, Weiden J, Sköld AE, Tel J, Figdor CG, de Vries IJM, Schreibelt G. 2016. A comparative study of the T cell stimulatory and polarizing capacity of human primary blood dendritic cell subsets. Mediators Inflamm. 2016:3605643.
- Sparber F. 2014. Langerhans cells: an update. J Dtsch Dermatol Ges. 12(12):1107–11.
- Steinman RM, Banchereau J. 2007. Taking dendritic cells into medicine. Nature. 449(7161):419–26.
- Strobl H, Krump C, Borek I. 2019. Micro-environmental signals directing human epidermal Langerhans cell differentiation. Semin Cell Dev Biol. 86:36–43.
- Swiecki M, Colonna M. 2015. The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol. 15(8):471–85.
- Tullett KM, Lahoud MH, Radford KJ. 2014. Harnessing human cross-presenting CLEC9A(+)XCR1(+) dendritic cells for immunotherapy. Front Immunol. 5:239.
- Turville SG, Cameron PU, Handley A, Lin G, Pöhlmann S, Doms RW, Cunningham AL. 2002. Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol. 3(10):975–83.
- Ueno H, Klechevsky E, Schmitt N, Ni L, Flamar A-L, Zurawski S, Zurawski G, Palucka K, Banchereau J, Oh S, et al. 2011. Targeting human dendritic cell subsets for improved vaccines. Semin Immunol. 23(1):21–27. doi:https://doi.org/10.1016/j.smim.2011.01.004.
- Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, Liu Y, Duvert-Frances V, Vincent C, Schmitt D, Davoust J, et al. 2000. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity. 12(1):71–81. doi:https://doi.org/10.1016/s1074-7613(00)80160-0.
- Vollmer J, Tluk S, Schmitz C, Jurk M, Forsbach A 2005. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med. 202(11):1575–85. doi:https://doi.org/10.1084/jem.20051696.
- Wu P, Wu J, Liu S, Han X, Lu J, Shi Y, Wang J, Lu L, Cao X. 2008. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients. Clin Immunol. 129(1):40–48.
- Yin Z, Dai J, Deng J, Sheikh F, Natalia M, Shih T, Lewis-Antes A, Amrute SB, Garrigues U, Doyle S, et al. 2012. Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells. J Immunol. 189(6):2735–45. doi:https://doi.org/10.4049/jimmunol.1102038.
- Yoshio S, Kanto T, Kuroda S, Matsubara T, Higashitani K, Kakita N, Ishida H, Hiramatsu N, Nagano H, Sugiyama M, et al. 2013. Human blood dendritic cell antigen 3 (BDCA3)+dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus. Hepatology. 57(5):1705–15. doi:https://doi.org/10.1002/hep.26182.